These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29180222)

  • 21. Outcomes and clinical implications of intranasal insulin administration to the central nervous system.
    Santiago JCP; Hallschmid M
    Exp Neurol; 2019 Jul; 317():180-190. PubMed ID: 30885653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
    J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease.
    Rosenbloom M; Barclay TR; Kashyap B; Hage L; O'Keefe LR; Svitak A; Pyle M; Frey W; Hanson LR
    Drugs Aging; 2021 May; 38(5):407-415. PubMed ID: 33719017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The brain as an insulin-sensitive metabolic organ.
    Milstein JL; Ferris HA
    Mol Metab; 2021 Oct; 52():101234. PubMed ID: 33845179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administration.
    Hallschmid M; Benedict C; Born J; Kern W
    Expert Opin Drug Deliv; 2007 Jul; 4(4):319-22. PubMed ID: 17683246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal Insulin Prevents Anesthesia-induced Cognitive Impairments in Aged Mice.
    Li X; Run X; Wei Z; Zeng K; Liang Z; Huang F; Ke D; Wang Q; Wang JZ; Liu R; Zhang B; Wang X
    Curr Alzheimer Res; 2019; 16(1):8-18. PubMed ID: 30381076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.
    Morgen K; Frölich L
    J Neural Transm (Vienna); 2015 Apr; 122(4):499-504. PubMed ID: 25673434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
    Duarte AI; Santos MS; Oliveira CR; Moreira PI
    Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.
    Chen Y; Guo Z; Mao YF; Zheng T; Zhang B
    Neurotox Res; 2018 May; 33(4):716-724. PubMed ID: 28929339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
    Mustapic M; Tran J; Craft S; Kapogiannis D
    J Alzheimers Dis; 2019; 69(2):489-498. PubMed ID: 30958348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
    Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
    Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for altered insulin receptor signaling in Alzheimer's disease.
    Griffith CM; Eid T; Rose GM; Patrylo PR
    Neuropharmacology; 2018 Jul; 136(Pt B):202-215. PubMed ID: 29353052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.
    Rajasekar N; Nath C; Hanif K; Shukla R
    Mol Neurobiol; 2017 Oct; 54(8):6507-6522. PubMed ID: 27730514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease.
    Stein MS; Scherer SC; Ladd KS; Harrison LC
    J Alzheimers Dis; 2011; 26(3):477-84. PubMed ID: 21694461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
    Ott V; Benedict C; Schultes B; Born J; Hallschmid M
    Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
    Reger MA; Watson GS; Green PS; Baker LD; Cholerton B; Fishel MA; Plymate SR; Cherrier MM; Schellenberg GD; Frey WH; Craft S
    J Alzheimers Dis; 2008 Apr; 13(3):323-31. PubMed ID: 18430999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease.
    Mejido DCP; Peny JA; Vieira MNN; Ferreira ST; De Felice FG
    Neuropharmacology; 2020 Jul; 171():108115. PubMed ID: 32344008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease.
    Hölscher C
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S33-7. PubMed ID: 24529523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.